Beijing SL Pharmaceutical Co. Ltd. received SFDA approval to begin producing a hepatitis drug and a second SFDA authorization to begin clinical trials of drug for male infertility. Adefovir dipivoxil, the drug newly approved for marketing, is aimed at hepatitis B. SL Pharma’s male infertility product is thought to be modafinil, the stimulant drug that is marketed as Provigil by Cephalon. More details...

Stock Symbols: (SZSE: 002038) (NSDQ: CEPH)